Bristol-Myers Squibb: An Attractive Investment Opportunity with Accelerating Sales of New Products
Trending News ☀️ BRISTOL-MYERS ($NYSE:BMY): Bristol-Myers Squibb (BMY) presents an attractive investment opportunity for investors due to its accelerating sales [...]
Bristol-Myers Squibb Company Reports Higher-Than-Expected Earnings Despite Lower-Than-Expected Revenue
Trending News 🌥️ BRISTOL-MYERS ($NYSE:BMY): Bristol-Myers Squibb Company (NYSE:BMY) reported higher-than-expected earnings despite lower-than-expected revenue in its latest earnings release. [...]
Bristol Myers Secures $1B Deal with Tubulis to Advance Cancer Treatments
Trending News 🌧️ BRISTOL-MYERS ($NYSE:BMY): Bristol Myers Squibb, a leading biopharmaceutical company, recently made headlines when it secured a licensing [...]
Bristol Myers Squibb and Foundation Medicine Partner to Create Diagnostic for Cancer Drug Repotrectinib
Trending News 🌧️ BRISTOL-MYERS ($NYSE:BMY): Bristol Myers Squibb is a leading pharmaceutical company that develops, manufactures and markets medicines for [...]
Bristol-Myers Squibb Reports Q4 FY2022 Earnings of $2.0 Billion, Down 14.8% Year-Over-Year.
Earnings Overview BRISTOL-MYERS ($NYSE:BMY): On February 2 2023, Bristol-Myers Squibb reported their FY2022 Q4 earnings results, with a 14.8% decrease [...]
BRISTOL-MYERS SQUIBB Reports FY2022 Q4 Earnings Results on February 2 2023
Earnings Overview On February 2 2023, BRISTOL-MYERS SQUIBB ($NYSE:BMY) reported its earnings results for the fourth quarter of FY2022, which [...]
BRISTOL-MYERS SQUIBB Reports FY2022 Q4 Earnings Results on February 2, 2023
Earnings Overview On February 2 2023, BRISTOL-MYERS SQUIBB ($NYSE:BMY) reported the financial results for Q4 of FY2022, which ended on [...]
BRISTOL-MYERS SQUIBB Reports Fourth Quarter FY2022 Earnings Results on February 2 2023
Earnings Overview On February 2 2023, BRISTOL-MYERS SQUIBB ($NYSE:BMY) reported total revenue of USD 2.0 billion for the fourth quarter [...]
BRISTOL-MYERS SQUIBB Reports Q4 Results with Total Revenue of USD 2.0 Billion and Net Income of USD 11.4 Billion, Year-Over-Year Decreases of 14.8% and 4.8%, Respectively.
Earnings Overview On February 2, 2023, BRISTOL-MYERS SQUIBB ($NYSE:BMY) reported their Q4 FY2022 financial results, which showed total revenue of [...]
BRISTOL-MYERS SQUIBB Reports Fourth Quarter Fiscal Year 2022 Financial Results on February 2 2023
Earnings Overview On February 2 2023, BRISTOL-MYERS SQUIBB ($NYSE:BMY) released their fourth quarter financial report for the fiscal year that [...]
